Evidence map›Paper›PMID 39996032›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

A network perspective on cognition in individuals with Parkinson's disease.

Daniel Scharfenberg, Elke Kalbe, Monika Balzer-Geldsetzer, Daniela Berg, Rüdiger Hilker-Roggendorf, Jan Kassubek, Inga Liepelt-Scarfone, Brit Mollenhauer, Kathrin Reetz, Oliver Riedel and 8 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Daniel ScharfenbergMedical Psychology, Neuropsychology and Gender Studies Center for Neuropsychological Diagnostics and Intervention (CeNDI) University Hospital Cologne and Faculty of Medicine University of Cologne Cologne Germany.ORCID https://orcid.org/0000-0003-2781-3143
Elke KalbeMedical Psychology, Neuropsychology and Gender Studies Center for Neuropsychological Diagnostics and Intervention (CeNDI) University Hospital Cologne and Faculty of Medicine University of Cologne Cologne Germany.ORCID https://orcid.org/0000-0001-8603-2545
Monika Balzer-GeldsetzerEthikkommission Ludwig-Maximilians-Universität München Munich Germany.
Daniela BergDepartment of Neurology University Medical Center Schleswig-Holstein, Christian Albrechts-University (CAU) Campus Kiel Kiel Germany.ORCID https://orcid.org/0000-0001-5796-5442
Rüdiger Hilker-RoggendorfDepartment of Neurology Klinikum Vest Recklinghausen Germany.
Jan KassubekDepartment of Neurology University Hospital Ulm Ulm Germany.ORCID https://orcid.org/0000-0002-7106-9270
Inga Liepelt-ScarfoneDepartment of Neurodegenerative Diseases Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases (DZNE) University Tübingen and German Center for Neurodegenerative Diseases Tübingen Germany.ORCID https://orcid.org/0000-0002-0875-892X
Brit MollenhauerDepartment of Neurology Paracelsus-Elena Klinik Kassel Germany.
Kathrin ReetzDepartment of Neurology RWTH Aachen University Hospital Aachen Germany.ORCID https://orcid.org/0000-0002-9730-9228
Oliver RiedelDepartment Clinical Epidemiology Leibniz Institute for Prevention Research and Epidemiology-BIPS Bremen Germany.ORCID https://orcid.org/0000-0002-1721-502X
Sandra RoeskeGerman Center for Neurodegenerative Diseases (DZNE) Bonn Germany.ORCID https://orcid.org/0000-0002-8262-4356
Jörg B SchulzDepartment of Neurology RWTH Aachen University Hospital Aachen Germany.ORCID https://orcid.org/0000-0002-8903-0593
Alexander StorchDepartment of Neurology University of Rostock and German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald Rostock Germany.ORCID https://orcid.org/0000-0002-1133-9216
Claudia TrenkwalderDepartment of Neurology Paracelsus-Elena Klinik Kassel Germany.
Karsten WittDepartment of Neurology School of Medicine and Health Sciences and Research Center Neurosensory Science University of Oldenburg Oldenburg Germany.
Hans-Ulrich WittchenClinical Psychology & Psychotherapy Ludwig-Maximilians-University Munich Munich Germany.
Richard DodelDepartment of Geriatric Medicine University Duisburg-Essen Essen Germany.ORCID https://orcid.org/0000-0003-2044-6299
Anja OpheyMedical Psychology, Neuropsychology and Gender Studies Center for Neuropsychological Diagnostics and Intervention (CeNDI) University Hospital Cologne and Faculty of Medicine University of Cologne Cologne Germany.ORCID https://orcid.org/0000-0001-5858-7762

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn neuropsychological diagnostics, the assignment of cognitive tests to domains is usually not empirically based. Hence, we aimed to assess the dimensionality structure of cognition in individuals with Parkinson's disease (PD) and conceptually replicate the findings in cognitively healthy individuals (CHIs).

methodsWe performed Exploratory Graph Analysis (EGA) for dimensionality analysis of cognitive test scores in

resultsEGA identified five dimensions. After removing redundancy identified by UVA, EGA identified a unidimensional structure of cognitive test scores. The findings were conceptually replicated in CHIs. DISCUSSION: The findings imply the need to re-evaluate the composition of cognitive test batteries to reduce redundancy and improve the validity of cognitive diagnostics. Cognition may be better described as a network of interrelated cognitive functions rather than a factorial structure of latent cognitive domains. Highlights: Cognitive test scores of the same paradigm were strongly associated with each other.This finding indicates redundancy in the cognitive test battery.After removing redundancy, scores were best represented by unidimensional structures.The findings in Parkinson's disease were conceptually replicated in healthy controls.The results suggest that cognition should be viewed as a complex "network" of interrelated functions.

Indexed as

cognitive declinecognitive domainsdimensionality analysismutualism hypothesisnetwork analysisnetwork neuropsychologyParkinson's disease

Identifiers

PMID39996032
PMCPMC11848640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.